Does TOFACITINIB Cause Hepatic enzyme increased? 6,269 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6,269 reports of Hepatic enzyme increased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 4.0% of all adverse event reports for TOFACITINIB.
6,269
Reports of Hepatic enzyme increased with TOFACITINIB
4.0%
of all TOFACITINIB reports
1,602
Deaths
2,323
Hospitalizations
How Dangerous Is Hepatic enzyme increased From TOFACITINIB?
Of the 6,269 reports, 1,602 (25.6%) resulted in death, 2,323 (37.1%) required hospitalization, and 1,848 (29.5%) were considered life-threatening.
Is Hepatic enzyme increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 6,269 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
PREDNISONE (5,897)
Which TOFACITINIB Alternatives Have Lower Hepatic enzyme increased Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN